Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction.
Marc D. Schwartz(Guardia Civil), Kathryn Komaridis(Georgetown University), Kathryn O'Mara(Georgetown University), Sarah P. Garnett, Tiffani A. DeMarco(Georgetown University), Sarah A. Kelleher(Icahn School of Medicine at Mount Sinai), Heather Bremer(Georgetown University), Rebecca A. Shelby(Duke University), Karen Brown(University of Leicester), Claudine Isaacs(Georgetown University), Suzanne C. O’Neill(Georgetown University), Jessica Rispoli(Icahn School of Medicine at Mount Sinai), Heiðdís Valdimarsdóttir(Reykjavík University), Sherry Grumet, Margaret M. McGovern(Icahn School of Medicine at Mount Sinai), Beth N. Peshkin(Georgetown University), William Lawrence(Georgetown University), Suzanne Leaman(Georgetown University)
Cited by 112
Related Papers
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
|New England Journal of Medicine|2012|1k
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Screening by Chest Radiograph and Lung Cancer Mortality
|JAMA|2011|659
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495